Cytokinetics
CYTK
#2458
Rank
A$10.78 B
Marketcap
A$88.21
Share price
-10.29%
Change (1 day)
20.13%
Change (1 year)

Earnings for Cytokinetics (CYTK)

Earnings in 2025 (TTM): -A$1.17 Billion

According to Cytokinetics 's latest financial reports the company's current earnings are A$87.21 Million. In 2024 the company made an earning of -A$0.83 Billion a decrease over its 2023 earnings that were of -A$0.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytokinetics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.17 Billion41.15%
2024 -A$0.83 Billion12.03%
2023 -A$0.74 Billion35.3%
2022 -A$0.55 Billion80.65%
2021 -A$0.31 Billion69.15%
2020 -A$0.18 Billion4.6%
2019 -A$0.18 Billion14.49%
2018 -A$0.15 Billion-16.83%
2017 -A$0.18 Billion-812.8%
2016 A$25.14 M-147.81%
2015 -A$52.6 Million156.05%
2014 -A$20.55 Million-56.56%
2013 -A$47.3 Million-16.48%
2012 -A$56.63 Million-15.65%
2011 -A$67.13 Million-3.24%
2010 -A$69.38 Million-308.68%
2009 A$33.24 M-141.87%
2008 -A$79.4 Million0.21%
2007 -A$79.23 Million-7.91%
2006 -A$86.04 Million37.42%
2005 -A$62.61 Million16.13%
2004 -A$53.91 Million-19.29%
2003 -A$66.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$11.56 B-1,196.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$43.56 Million-95.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$93.68 M-108.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.39 Billion-63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.18 M-100.59%๐Ÿ‡บ๐Ÿ‡ธ USA